These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9228035)

  • 1. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor.
    Kiyokawa N; Lee EK; Karunagaran D; Lin SY; Hung MC
    J Biol Chem; 1997 Jul; 272(30):18656-65. PubMed ID: 9228035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
    Liu Y; Li R; Ladisch S
    J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
    Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.
    Tanaka T; Zhou Y; Ozawa T; Okizono R; Banba A; Yamamura T; Oga E; Muraguchi A; Sakurai H
    J Biol Chem; 2018 Feb; 293(7):2288-2301. PubMed ID: 29255092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
    Justman QA; Clinton GM
    J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
    Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
    J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
    Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
    J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation.
    Nandagopal K; Popp DM; Niyogi SK
    J Cell Biochem; 2001 Aug 1-9; 83(2):326-41. PubMed ID: 11573249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling.
    Pascarelli S; Merzhakupova D; Uechi GI; Laurino P
    J Biol Chem; 2021 Jul; 297(1):100872. PubMed ID: 34126069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
    Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
    Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor.
    Chen X; Resh MD
    J Biol Chem; 2002 Dec; 277(51):49631-7. PubMed ID: 12397069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of an epidermal growth factor receptor/RET chimera.
    Pandit SD; O'Hare T; Donis-Keller H; Pike LJ
    J Biol Chem; 1997 Jan; 272(4):2199-206. PubMed ID: 8999923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor.
    Wang XQ; Sun P; Paller AS
    J Biol Chem; 2002 Dec; 277(49):47028-34. PubMed ID: 12354760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensification of growth factor receptor signalling by phorbol treatment of ligand-primed cells implies a dimer-stabilizing effect of protein kinase C-dependent juxtamembrane domain phosphorylation.
    Gulliford T; Ouyang X; Epstein RJ
    Cell Signal; 1999 Apr; 11(4):245-52. PubMed ID: 10372802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.